Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0192623309335062v1
37/4/446    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dewa, Y.
Right arrow Articles by Mitsumori, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dewa, Y.
Right arrow Articles by Mitsumori, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Liver Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Molecular Expression Analysis of β-Naphthoflavone-induced Hepatocellular Tumors in Rats

Yasuaki Dewa1,2, Jihei Nishimura1,2, Meilan Jin1,3, Masaomi Kawai1,2, Yukie Saegusa1,2, Tomoaki Harada1, Makoto Shibutani1 and Kunitoshi Mitsumori1

1 Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, Tokyo, Japan
2 Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, Gifu, Japan
3 Department of Applied Biological Science, United Graduate School of Agricultural Sciences, Tokyo University of Agriculture and Technology, Tokyo, Japan

Correspondence: Kunitoshi Mitsumori, Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; e-mail:mitsumor{at}cc.tuat.ac.jp.

The present study was performed to characterize molecular expression levels of preneoplastic and neoplastic lesions induced by β-naphthoflavone (BNF), an aryl hydrocarbon receptor (AhR) agonist in rat hepatocarcinogenesis. Male F344 rats were initiated with an intraperitoneal injection of 200 mg/kg N-diethylnitrosamine, and two weeks later, they were fed a diet containing 0% or 1% BNF for twenty-eight weeks. All animals were subjected to a two-thirds partial hepatectomy at week 3 and sacrificed at week 30. Histopathologically, BNF increased the incidence and multiplicity of altered foci (1.7-fold and 3.3-fold) and hepatocellular adenomas (HCAs) (4.0-fold and 4.7-fold). Immunohistochemically, BNF increased the number of proliferating cell nuclear antigen (PCNA)-positive cells in altered foci (2.3-fold) and HCAs (6.7-fold) compared with the surrounding tissue and decreased the staining of cell cycle regulators (P21, C/EBP{alpha}). In addition, loss of reactivity for AhR-regulated (CYP1A1, CYP1B1) molecules and increased reactivity of Nrf-2-regulated (AKR7, GPX2) molecules were also observed in proliferative lesions. Furthermore, increased staining of histone deacetylase (HDAC1) in the nucleus was prominent in HCAs. The differential expression patterns were confirmed at mRNA levels by real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis. These results suggest that enhanced cell proliferation and protection against oxidative stress play an important role in BNF-induced hepatocarcinogenesis in rats.

Key Words: β-naphthoflavone • hepatocarcinogenesis • tumor promotion • oxidative stress • cell proliferation • histone deacetylase • rat

Abbreviations: Afar, aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase, Akr7a3); • AhR, aryl hydrocarbon receptor; • AKR7, aldo-keto reductase family 7; • BNF, β-naphthoflavone; • C/EBP{alpha}, CCAAT/ enhancer binding protein alpha; • CYP1A1, cytochrome P450, family 1, subfamily a, polypeptide 1; • CYP1B1, cytochrome P450, family 1, subfamily b, polypeptide 1; • DEN, N-diethylnitrosamine; • Gpx2, glutathione peroxidase 2; • GST-P, glutathione S-transferase placental form; • HCA, hepatocellular adenoma; • HDAC1, histone deacetylase 1; • HDACi, histone deacetylase inhibitor; • Nrf2, NF-E2-related factor 2; • p21, cyclin-dependent kinase inhibitor 1A; • PCNA, proliferating cell nuclear antigen; • real-time RT-PCR, real-time reverse transcription-polymerase chain reaction.

This version was published on June 1, 2009

Toxicologic Pathology, Vol. 37, No. 4, 446-455 (2009)
DOI: 10.1177/0192623309335062


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?